Literature DB >> 30905578

In vitro-Transcribed mRNA Therapeutics: Out of the Shadows and Into the Spotlight.

Katalin Karikó1.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30905578      PMCID： PMC6453554          DOI： 10.1016/j.ymthe.2019.03.009

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  5 in total

Review 1.  Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery.

Authors:  Piotr S Kowalski; Arnab Rudra; Lei Miao; Daniel G Anderson
Journal:  Mol Ther       Date:  2019-02-19       Impact factor: 11.454

Review 2.  Genome Editing with mRNA Encoding ZFN, TALEN, and Cas9.

Authors:  Hong-Xia Zhang; Ying Zhang; Hao Yin
Journal:  Mol Ther       Date:  2019-01-25       Impact factor: 11.454

Review 3.  mRNA: A Novel Avenue to Antibody Therapy?

Authors:  Thomas Schlake; Moritz Thran; Katja Fiedler; Regina Heidenreich; Benjamin Petsch; Mariola Fotin-Mleczek
Journal:  Mol Ther       Date:  2019-03-06       Impact factor: 11.454

Review 4.  Delivery of mRNA Therapeutics for the Treatment of Hepatic Diseases.

Authors:  Zeljka Trepotec; Eva Lichtenegger; Christian Plank; Manish K Aneja; Carsten Rudolph
Journal:  Mol Ther       Date:  2018-12-22       Impact factor: 11.454

Review 5.  mRNA-Based Protein Replacement Therapy for the Heart.

Authors:  Ajit Magadum; Keerat Kaur; Lior Zangi
Journal:  Mol Ther       Date:  2018-12-06       Impact factor: 11.454
  5 in total
  13 in total

Review 1.  Empowering patients from within: Emerging nanomedicines for in vivo immune cell reprogramming.

Authors:  Matthias T Stephan
Journal:  Semin Immunol       Date:  2021-11-26       Impact factor: 11.130

Review 2.  mRNA-based modalities for infectious disease management.

Authors:  Mengjie Zhang; Abid Hussain; Haiyin Yang; Jinchao Zhang; Xing-Jie Liang; Yuanyu Huang
Journal:  Nano Res       Date:  2022-07-06       Impact factor: 10.269

3.  Self-assembled miRNA-switch nanoparticles target denuded regions and prevent restenosis.

Authors:  John H Lockhart; Jeffrey VanWye; Richa Banerjee; Samuel A Wickline; Hua Pan; Hana Totary-Jain
Journal:  Mol Ther       Date:  2021-02-03       Impact factor: 11.454

Review 4.  From Recoding to Peptides for MHC Class I Immune Display: Enriching Viral Expression, Virus Vulnerability and Virus Evasion.

Authors:  John F Atkins; Kate M O'Connor; Pramod R Bhatt; Gary Loughran
Journal:  Viruses       Date:  2021-06-27       Impact factor: 5.048

Review 5.  Modified mRNA-Based Vaccines Against Coronavirus Disease 2019.

Authors:  Aline Yen Ling Wang
Journal:  Cell Transplant       Date:  2022 Jan-Dec       Impact factor: 4.139

6.  Phosphodiester modifications in mRNA poly(A) tail prevent deadenylation without compromising protein expression.

Authors:  Dominika Strzelecka; Miroslaw Smietanski; Pawel J Sikorski; Marcin Warminski; Joanna Kowalska; Jacek Jemielity
Journal:  RNA       Date:  2020-08-20       Impact factor: 4.942

Review 7.  The Limitless Future of RNA Therapeutics.

Authors:  Tulsi Ram Damase; Roman Sukhovershin; Christian Boada; Francesca Taraballi; Roderic I Pettigrew; John P Cooke
Journal:  Front Bioeng Biotechnol       Date:  2021-03-18

8.  Heterogeneous Longitudinal Antibody Responses to Covid-19 mRNA Vaccination.

Authors:  Suzanne M de la Monte; Christine Long; Nicole Szczepanski; Christopher Griffin; Amanda Fitzgerald; Kimberle Chapin
Journal:  Clin Pathol       Date:  2021-10-07

9.  mRNA Transfection-Induced Activation of Primary Human Monocytes and Macrophages: Dependence on Carrier System and Nucleotide Modification.

Authors:  Hanieh Moradian; Toralf Roch; Andreas Lendlein; Manfred Gossen
Journal:  Sci Rep       Date:  2020-03-06       Impact factor: 4.379

Review 10.  Recent Advances in RNA Therapy and Its Carriers to Treat the Single-Gene Neurological Disorders.

Authors:  Ming-Jen Lee; Inyoul Lee; Kai Wang
Journal:  Biomedicines       Date:  2022-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.